Does haemophilia influence cancer-related mortality in HIV-negative patients?

Haemophilia

Volumn 17, Issue 1, 2011, Pages 55-60

  Miesbach, W ^a   Seifried, E ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b German Red Cross Blood Service West   (Germany)

Author keywords

Cancer; Co morbidity; Haemophilia; HCV; HIV negative; Malignancy

Indexed keywords

BLOOD CLOTTING FACTOR;

ARTICLE; CANCER MORTALITY; DISEASE ASSOCIATION; HEALTH SURVEY; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER FAILURE; NEOPLASM; PRIORITY JOURNAL; STANDARDIZED MORTALITY RATIO;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOPHILIA A; HIV SERONEGATIVITY; HUMANS; INFANT; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; YOUNG ADULT;

EID: 79951933128     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02364.x     Document Type: Article

References (35)

1. Chorba TL, Holman RC, Clarke MJ, Evatt BL. Effects of HIV infection on age and cause of death for persons with haemophilia A in the United States. Am J Hematol 2001; 66: 229-40.
2. Makris M, Preston FE, Triger DR et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335: 1117-9.
3. Pallela FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
4. Winter M. The practical management of haemophilia. Blood Rev 1992; 6: 174-81.
5. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 2000; 96: 437-42.
6. Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.
7. Miesbach W, Alesci S, Krekeler S, Seifried E. Co-morbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15: 894-9.
8. Darby SC, Ewart DW, Giangrande PL et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997; 350: 1425-31.
9. Ragni MV, Belle SH, Bass D, Duerstein S, Kingsley LA. Clinical characteristics and blood product usage in AIDS-associated lymphoma in haemophiliacs: a case-control study. Haemophilia 1998; 4: 826-35.
10. Zwicker JI, Furie BC, Furie B. Cancer-associated thrombosis. Crit Rev Oncol Hematol 2007; 62: 126-36.
11. Kakkar AK, Levine MN, Kadziola Z et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004; 22: 1944-8.
12. Klerk CP, Smorenburg SM, Otten HM et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 2005; 23: 2130-5.
13. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
14. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumour-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229-36.
15. Langer F, Amirkhosravi A, Ingersoll SB et al. Experimental metastasis and primary tumor growth in mice with hemophilia A. J Thromb Haemost 2006; 4: 1056-62.
16. Brüggemann LW, Versteeg HH, Niers TM, Reitsma PH, Spek CA. Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med 2008; 12: 2622-7.
17. Franchini M. Hepatitis C in haemophiliacs. Thromb Haemost 2004; 92: 1259-68.
18. Goedert JJ, Eyster ME, Lederman MM et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002; 100: 1584-9.
19. Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada. Haemophilia 1998; 4: 714-20.
20. Tagliaferri A, Rivolta GF, Iorio A et al. Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia 2010; 16: 437-46.
21. Dunn AL. Malignancy in patients with haemophilia: a review of the literature. Haemophilia 2010; 16: 427-36.
22. Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with haemophilia. Br J Haematol 2009; 148: 522-33.
23. Franchini M, Lippi G, Montagnana M et al. Hemophilia and cancer: a new challenge for hemophilia centers. Cancer Treat Rev 2009; 35: 374-7.
24. Plug I, Van Der Bom JG, Peters M et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-6.
25. Martin D, Gutkind JS. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 2008; 27(Suppl. 2): S31-42.
26. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 1823-30.
27. Franchini M, Montagnana M, Targher G, Manzato F, Lippi G. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis 2007; 24: 29-38.
28. Ruf W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 2006; 32(Suppl. 1): 61-8.
29. Snyder KM, Kessler CM. The pivotal role of thrombin in cancer biology and tumorigenesis. Semin Thromb Hemost 2008; 34: 734-41.
30. Aronson DL. Cause of death in hemophilia A patients in the United States from 1968 to 1979. Am J Hematol 1988; 27: 7-12.
31. Reitter S, Waldhoer T, Vutuc C, Lechner K, Pabinger I. Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006. Haemophilia 2009; 15: 888-93.
32. Arnold DM, Julian JA, Walker IR, Association of Hemophilia Clinic Directors of Canada. Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21years of follow-up. Blood 2006; 108: 460-4.
33. Koumbarelis E, Rosendaal FR, Gialeraki A et al. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994; 72: 808-13.
34. Rosendaal FR, Varekamp I, Smit C et al. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989; 71: 71-6.
35. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briët E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995; 123: 823-7.